About: AMR
Health Brief: DG SANTE’s to-do list
Welcome to EURACTIV’s very first Health Brief! In this first edition, we spoke to the European Commission's director-general for health and food safety, Sandra Gallina, to find out what is in store this autumn when it comes to health.
Agrifood Brief: Fertile ground for a ruckus
Welcome to EURACTIV’s AgriFood Brief, your weekly update on all things Agriculture & Food in the EU. You can subscribe here if you haven’t done so yet. This week: EURACTIV’s agrifood team digs deeper into a controversial vote in the...
Parliament sides with Commission to approve controversial new antimicrobials rules
The European Parliament has given its green light to a controversial new antimicrobials regulation, dismissing a motion calling for tighter restrictions on antibiotics use in animals and allowing the Commission to move forward on its plans to tackle anti-microbial resistance.
Greens wage battle against Commission over antimicrobials regulation
A new delegated act proposed by the European Commission to tackle anti-microbial resistance (AMR) has drawn harsh criticisms from the Green group in the European Parliament, who are calling for the use of antibiotics in animals to be restricted.
EU action to turn the AMR tide looks at different incentive models
EU policymakers are being urged to consider the full range of new incentive systems and pilot innovative approaches to tackle antimicrobial resistance (AMR), including Netflix-style subscription services and pull incentives.
Heavy use of antibiotics in COVID-19 treatment likely to increase AMR
COVID-19 pandemic has helped raise political awareness of health issues but the widespread misuse of antibiotics in COVID patient treatment is likely to result in increased antimicrobial resistance, health experts have warned.
Netflix and pill: Industry subscription service could incentivise antibiotic research, says expert
A ‘Netflix-style’ subscription service, regularly paid from governments to the pharmaceutical industry, could help incentivise the creation of sorely-needed new antibiotics and break the “toxic” environment of antibiotic research and development, according to an expert.
MEP: Public-private partnerships needed to face silent threat of AMR
Investment in research and development, together with encouraging the innovative economic models is a way to fight this silent threat, Swedish centre-right MEP Jessica Polfjärd told EURACTIV in an interview.
MEP: Livestock breeding ‘neglected’ in fight to tackle antimicrobial resistance
Animal breeding has been neglected in the conversation on tackling the looming global crisis of antimicrobial resistance, according to Green MEP Sarah Weiner, who stressed a need to focus on breeding animals for resilience over productivity.
Commission: Antimicrobial resistance among biggest global health threats
The European Commission backs the stance of the World Health Organisation (WHO) on the importance of approaching the issue of antimicrobial resistance (AMR) in a multilateral, global way.
Expert: Antimicrobial resistance is the ‘new climate change’
Diseases evolving to become resistant to medicines is a hidden threat to humanity as dangerous as climate change, an animal health expert has told EURACTIV, warning that more must be done to reduce the use of antimicrobials in agriculture.
US-UK imports of meat raised with antibiotics risk undermining EU farmers
Trade of meat from animals raised with antibiotics between the United Kingdon and the United States threatens the progress recently made on antibiotic resistance and risks adversely affecting both British and EU meat producers, warns a new report published on Tuesday (1 December).
EU ponders new incentives for novel antibiotics
The European Commission will examine specific incentives and a new pricing system to develop innovative antibiotics in its pharmaceutical strategy, in a bid to take a more ambitious stance against the rising threat of anti-microbial resistance (AMR).
Pharma official: Anti-microbial resistance larger than COVID-19 crisis
Antimicrobial resistance (AMR) is a looming crisis and potentially “even larger than the COVID-19” pandemic, the CEO of one of the few remaining antibiotic producers with a manufacturing presence in the EU told EURACTIV in an interview.
EU agency reports cases of Salmonella after contaminated imported nuts
An outbreak of Salmonella Typhimurium linked to Brazil nuts imported from Bolivia has been reported in several EU countries, prompting the European Commission to trigger its rapid alert system.
Taking action on the global threat of superbugs
COVID-19 has demonstrated in a quite dramatic way the huge impact of a global threat on public health and economy. While the COVID-19 crisis took us by surprise, our world faces a silent threat that is predictable and preventable, writes Hubertus Von Baumbach, the CEO of pharmaceutical company Boehringer Ingelheim.
AMR: Foodborne superbugs harder to beat, EU agencies say
Foodborne bacteria such as Salmonella, Campylobacter and E. Coli are getting harder to treat as they are becoming increasingly resistant to antibiotics used to beat them, two EU agencies warned in a report published on Tuesday (3 March).
Kyriakides: Curbing pesticide dependency to set a world sustainable standard
Currently renowned for producing safe, nutritious and high-quality foodstuffs, the European farming sector should also become a world standard for sustainability, according to the new Food Safety Commissioner Kyriakides. InfographicPromoted content
Medical technology’s role in the fight against AMR/HAIs
Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HAI) are among the biggest global public health challenges of our time. Medical technologies can address these problems by preventing, detecting, monitoring and managing infections and resistance. Find out more: https://amr.medtecheurope.org/files/MedTech_Europe_AMR_Infographic_2019.pdf
AMR incentives could be next big EU opportunity, pharma boss says
Europe could become the first region worldwide to incentivise the fight anti-microbial resistance (AMR), Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), told EURACTIV in an interview.
Commission: Third countries should meet EU antibiotics requirements on animal exports
Non-EU countries that export animals and animal products to the bloc will have to abide by new rules on veterinary medicines when it comes to the use of antibiotics, according to the European Commission.
Innovation in animal health: Sifting the tangible actions from the political ideas
Over the past fifty years, the EU has done a stellar job in moving from a very fragmented national approach to animal disease control to a progressively more harmonised system of animal health measures, disease surveillance, diagnosis and control, writes Roxane Feller.
Expert: Animal health innovations will benefit both farming and society
An innovation-driven approach – ranging from vaccination to other health management solutions and appropriate biosecurity measures – will ensure more sustainable future livestock farming and protection of public health, as animal diseases do not recognise borders, Roxane Feller told EURACTIV.com.